in

Big Tobacco proposes nearly $24 billion payment to settle Canada lawsuits

The Canadian units of the three tobacco giants were dealt a massive blow in 2015 after a Quebec court awarded damages to some 100,000 smokers and ex-smokers who alleged the companies knew since the 1950s their product was causing cancer, other illnesses and failed to warn consumers adequately.

After an appeal, a Quebec court in 2019 upheld the 2015 decision that awarded smokers in the Canadian province around C$15 billion, forcing the Canadian subsidiaries of all three companies to seek bankruptcy protection.

The subsidiaries have been under a court-supervised mediation process negotiating a possible settlement since then.

The allocation of the aggregate settlement amount between the tobacco giants remains unresolved, according to Philip Morris.

“Although important issues with the plan remain to be resolved, we are hopeful that this legal process will soon conclude, allowing RBH (Rothmans, Benson & Hedges) and its stakeholders to focus on the future,” Philip Morris CEO Jacek Olczak said in a statement on Friday.

Rothmans, Benson & Hedges is Philip Morris’ Canadian unit.

British American Tobacco earlier on Friday said that the proposed plan marked a positive step towards finding a resolution. It did not provide details of the plan that Philip Morris did.

BAT (LON:BATS) said its unit Imperial Tobacco Canada supported the settlement framework and structure and that the settlement would be funded by cash on hand and cash generated from the future sale of tobacco products in Canada.

BAT shares fell 3% on Friday morning.

Philip Morris said that voting on the plan would happen in December this year and if accepted by claimants, a hearing to consider approval of the plan would then be expected in the first half of next year.

Japan Tobacco did not immediately respond to Reuters’ request for comment.

($1 = 1.3792 Canadian dollars)


Source: Economy - investing.com

CVS replaces CEO, pulls profit forecast as investor pressure mounts

Procter & Gamble earnings beat estimates, but weak demand in China hurts sales